Jeremy Simpson, University of Guelph
Associate Professor
Guelph, Ontario
jeremys@uoguelph.ca
Office:
(519) 824-4120 ext. 53576
(519) 824-4120 ext. 56629
Expert In
Cardiac hypertrophy
Cardio-respiratory physiology
Cell culture techniques
Classical physiology
Fatigue
Heart failure
Hypertension
Hypoxic conditions
Long-term morbidity
Novel cardiac protein hormones
Pathophysiology
Premature feath
Proteomic techniques
Skeletal and cardiomyocyte cell signalling
Valvular disease
Bio/Research
Dr. Simpson uses classical physiology combined with proteomic techniques to study cardio-respiratory physiology and pathophysiology in multiple areas.
Heart failure remains the predominant cause of premature death and long-term morbidity in western society. Cardiac hypertrophy (increase ...
Click to Expand >>
Heart failure remains the predominant cause of premature death and long-term morbidity in western society. Cardiac hypertrophy (increase ...
Click to Expand >>
Bio/Research
Dr. Simpson uses classical physiology combined with proteomic techniques to study cardio-respiratory physiology and pathophysiology in multiple areas.
Heart failure remains the predominant cause of premature death and long-term morbidity in western society. Cardiac hypertrophy (increase in cell size) develops in such conditions of chronic hemodynamic overload as hypertension and valvular disease. Although the initial hypertrophy is critical as a compensatory response, it eventually becomes maladaptive, leading to contractile dysfunction and myocyte apoptosis. Eventually, heart failure occurs. Thus, a major goal of Simpson's lab is to better understand how the heart initially adapts to hypertension before the development of contractile dysfunction and heart failure. Simpson's lab believes this will lead to a better understanding of why the heart begins to fail and will ultimately lead to new targets for the treatment of heart failure.
Simpson is also interested in skeletal and cardiomyocyte cell signalling during normal and hypoxic conditions, both between the muscle cells and with other tissues in the body. His research combines cell culture techniques with cutting-edge proteomic tools to identify novel cardiac protein hormones. He uses different models to investigate their functional effects in vitro and in vivo.
While much is known about the development of exercise-induced fatigue of limb muscles, little is known about the proteomic alterations that occur during exercise that contribute to or compensate for contractile dysfunction. Interestingly, Simpson's lab has shown skeletal myofilament proteins undergo specific and progressive modifications during the development of muscle fatigue. Current work is aimed at identifying key post-translational modifications of myofilament proteins that arise during the development of whole muscle dysfunction as a result of fatigue or ischemia and delineating their role(s) in contraction. Simpson's lab has identified several key myofilament proteins that are altered in animal models but are potentially involved in the development of fatigue in humans.
Click to Shrink <<
Heart failure remains the predominant cause of premature death and long-term morbidity in western society. Cardiac hypertrophy (increase in cell size) develops in such conditions of chronic hemodynamic overload as hypertension and valvular disease. Although the initial hypertrophy is critical as a compensatory response, it eventually becomes maladaptive, leading to contractile dysfunction and myocyte apoptosis. Eventually, heart failure occurs. Thus, a major goal of Simpson's lab is to better understand how the heart initially adapts to hypertension before the development of contractile dysfunction and heart failure. Simpson's lab believes this will lead to a better understanding of why the heart begins to fail and will ultimately lead to new targets for the treatment of heart failure.
Simpson is also interested in skeletal and cardiomyocyte cell signalling during normal and hypoxic conditions, both between the muscle cells and with other tissues in the body. His research combines cell culture techniques with cutting-edge proteomic tools to identify novel cardiac protein hormones. He uses different models to investigate their functional effects in vitro and in vivo.
While much is known about the development of exercise-induced fatigue of limb muscles, little is known about the proteomic alterations that occur during exercise that contribute to or compensate for contractile dysfunction. Interestingly, Simpson's lab has shown skeletal myofilament proteins undergo specific and progressive modifications during the development of muscle fatigue. Current work is aimed at identifying key post-translational modifications of myofilament proteins that arise during the development of whole muscle dysfunction as a result of fatigue or ischemia and delineating their role(s) in contraction. Simpson's lab has identified several key myofilament proteins that are altered in animal models but are potentially involved in the development of fatigue in humans.
Click to Shrink <<